Published • loading... • Updated
Hundreds of deaths suspected of being linked to weight-loss jabs reported to regulator
The regulator said the reports cover more than 158,000 adverse reactions, while stressing they do not prove the medicines caused the deaths.
- Health officials have received reports of more than 200 deaths suspected of being linked to weight-loss jabs, according to figures from the Medicines and Healthcare Products Regulatory Agency .
- Patients and medical professionals submit these reports through the MHRA Yellow Card scheme, designed to flag potential safety signals for medications including Wegovy, Mounjaro, and Saxenda.
- Mounjaro recorded more than 100,000 complaints and 98 fatal outcomes, while semaglutide and liraglutide each reported 37 fatal outcomes, according to Yellow Card data.
- Experts caution against interpreting raw figures as proof of harm, while manufacturers Eli Lilly and Novo Nordisk stated they actively monitor safety information for all medicines.
- Clinical trials show GLP-1 medications reduced major cardiovascular events by 20% compared to placebos, demonstrating that for many patients the benefits outweigh potential side effects.
Insights by Ground AI
58 Articles
58 Articles
In the UK, more than 100 deaths have been reported in connection with the use of the obesity drugs Mounjaro, Wegovy and Saxenda. Does this mean they are dangerous?
·Stockholm, Sweden
Read Full Article
Coverage Details
Total News Sources58
Leaning Left7Leaning Right15Center25Last UpdatedBias Distribution53% Center
Bias Distribution
- 53% of the sources are Center
53% Center
15%
C 53%
R 32%
Factuality
To view factuality data please Upgrade to Premium
